The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 343.80
Bid: 343.00
Ask: 343.60
Change: 2.60 (0.76%)
Spread: 0.60 (0.175%)
Open: 335.80
High: 344.80
Low: 335.80
Prev. Close: 341.20
ROR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

25 Nov 2020 07:00

RNS Number : 3913G
Rotork PLC
25 November 2020
 

25 November 2020

Rotork Plc

Trading update

Improved resilience demonstrated and guidance reinstated

Rotork plc ("Rotork"), the global flow control and instrumentation group, today issues the following trading update covering the four months to 1 November 2020.

Trading update

Order intake in the third quarter showed sequential improvement, whilst remaining lower year-on-year on an OCC1 basis, with the decline slightly less than the 15.6% experienced in the first half. The majority of Rotork's activity is driven by customers' operational rather than capital expenditure and they continue to spend on automation and environmental projects as well as maintenance and refurbishment. Large project activity has remained subdued.

During the third quarter Group revenues were at 97% of the 2019 level on an OCC basis, an improvement on the first-half's 9.6% year-on-year decline. The third quarter performance largely reflected reduced activity at Rotork Site Services.

Oil & Gas sales declined more than the Group, with revenue higher year-on-year in the quarter in EMEA and Asia Pacific, but lower in the Americas. Water & Power sales grew, continuing the encouraging performance seen earlier in the year. Trading conditions remained mixed at CPI, however the Asia Pacific region returned to year-on-year growth. Overall, CPI revenue was down less than in the first half (when CPI sales were 16.8% lower).

Third quarter adjusted operating profit margins benefited from continued execution of the Growth Acceleration Programme and other management actions and we now anticipate full-year margin progress year-on-year, absent any further Covid-19 related disruption to operations.

Our Growth Acceleration Programme is on track. Our innovation and new product development initiatives are progressing well and the second half features several important launches. Our factory footprint optimisation work continues, and we recently formally opened our expanded Rochester, New York, facility. The regional back office simplification initiative is well under way.

Rotork remains highly cash generative with a strong balance sheet. Net cash at 1 November 2020 was £146.8m (£106.1m at 31 December 2019 including £10.7m of lease liabilities) after paying an interim dividend on 25 September 2020 of £34.0m in lieu of the deferred 2019 final dividend.

Covid-19 update

Our priority is the health and safety of our colleagues and their families, our customers, and suppliers. We continue to take decisive actions to manage the Covid-19 situation.

All our production facilities are currently open, albeit in a small number of cases operating at below normal output levels. Whilst every effort is being made to keep our facilities open, we will not hesitate to close them if required or if we believe there is any risk to our colleagues or their families.

Outlook

The Group's performance in the first ten months has demonstrated the improved resilience of the business. Although there remains uncertainty on the continuing impact of the Covid-19 pandemic, and risks of temporary factory closures and logistics issues, we expect 2020 adjusted operating profit to be at, or slightly above, the top end of the range of current market expectations2.

Rotork will publish 2020 full-year results on Tuesday 2 March 2021.

¹ OCC is organic constant currency results excluding discontinued businesses and restated at 2019 exchange rates

2 The current range of market expectations (company compiled) for 2020 adjusted operating profit is £124m-136m

 

Enquiries:

Rotork plc Tel: +44 (0)1225 733 200

Kevin Hostetler, Chief Executive

Jonathan Davis, Finance Director

Andrew Carter, Investor Relations Director

 

FTI Consulting Tel: + 44 (0)20 3727 1340

Nick Hasell / Susanne Yule

 

About Rotork

Rotork is a market-leading global provider of mission-critical flow control and instrumentation solutions for oil & gas, water and wastewater, power, chemical process and industrial applications. We help customers around the world to improve efficiency, reduce emissions, minimise their environmental impact and assure safety. Rotork employs about 3,500 people, has manufacturing facilities in more than 20 locations and serves 173 countries through a global service network. Its shares have a premium listing on the London Stock Exchange (symbol: ROR) and are a constituent of the FTSE 250 index. For more information please visit www.rotork.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFETLALSFII
Date   Source Headline
17th Dec 20183:24 pmRNSDirector/PDMR Shareholding
6th Dec 20184:04 pmRNSHolding(s) in Company
4th Dec 20189:57 amRNSDirector/PDMR Shareholding
3rd Dec 201810:32 amRNSTotal Voting Rights
28th Nov 20187:00 amRNSDirectorate Change
23rd Nov 20183:30 pmRNSDirector/PDMR Shareholding
23rd Nov 20183:30 pmRNSDirector/PDMR Shareholding
22nd Nov 20187:00 amRNSTrading Update
5th Nov 20188:06 amRNSDirector Declaration
2nd Nov 20182:10 pmRNSDirector/PDMR Shareholding
2nd Nov 20182:10 pmRNSHolding(s) in Company
1st Nov 20181:45 pmRNSTotal Voting Rights
22nd Oct 20183:07 pmRNSDirector/PDMR Shareholding
1st Oct 201810:12 amRNSTotal Voting Rights
28th Sep 20189:11 amRNSDirector/PDMR Shareholding
24th Sep 20184:34 pmRNSDirector/PDMR Shareholding
23rd Aug 20182:35 pmRNSHolding(s) in Company
22nd Aug 20181:17 pmRNSDirector/PDMR Shareholding
20th Aug 20183:10 pmRNSHolding(s) in Company
9th Aug 20189:20 amRNSDirector Declaration
7th Aug 20187:00 amRNS2018 Half Year Results
2nd Aug 20185:21 pmRNSCompany Secretary Change
20th Jul 20182:51 pmRNSDirector/PDMR Shareholding
2nd Jul 201810:19 amRNSBlock listing Interim Review
2nd Jul 201810:18 amRNSTotal Voting Rights
22nd Jun 201812:10 pmRNSDirector/PDMR Shareholding
6th Jun 20183:26 pmRNSTotal Voting Rights
29th May 20189:51 amRNSDirector Declaration
21st May 20182:55 pmRNSDirector/PDMR Shareholding
11th May 20183:16 pmRNSHolding(s) in Company
8th May 201811:47 amRNSHolding(s) in Company
1st May 20185:33 pmRNSHolding(s) in Company
1st May 201810:49 amRNSTotal Voting Rights
27th Apr 20185:17 pmRNSDirector/PDMR Shareholding
27th Apr 20185:00 pmRNSDirector/PDMR Shareholding
27th Apr 20183:41 pmRNSResult of AGM
23rd Apr 20187:00 amRNSTrading Update
20th Apr 20184:36 pmRNSDirector/PDMR Shareholding
6th Apr 201810:01 amRNSHolding(s) in Company
3rd Apr 20189:24 amRNSTotal Voting Rights
26th Mar 201812:41 pmRNSDoc re. AGM Documents
22nd Mar 20184:22 pmRNSDirector/PDMR Shareholding
22nd Mar 20184:22 pmRNSDirector/PDMR Shareholding
22nd Mar 20184:21 pmRNSDirector/PDMR Shareholding
19th Mar 20184:48 pmRNSDirector/PDMR Shareholding
16th Mar 20183:42 pmRNSDirector/PDMR Shareholding
16th Mar 20183:39 pmRNSDirector/PDMR Shareholding
16th Mar 20183:38 pmRNSDirector/PDMR Shareholding
16th Mar 20183:36 pmRNSDirector/PDMR Shareholding
16th Mar 20183:35 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.